To study the influence of CYP2C19 polymorphism on bortezomib blood concentration and clinical response in in myeloma patients | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

To study the influence of CYP2C19 polymorphism on bortezomib blood concentration and clinical response in in myeloma patients

Implementing Organization

All India Institute of Medical Sciences

Principal Investigator

Dr. Pooja Gupta

Assistant Professor

|

All India Institute of Medical Sciences

Related Research

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

Myeloma

Start Year

2017

Sanction Amount

₹ 25.31 L

Status

completed

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

N/A

Startup (If Any)

00

No. of Patents

Filed :00

Grant :00